New facility will strengthen the security of supply for global pharmaceutical and biotech customers and will support the continued development and production of lifesaving clinical and commercial-scale therapeutics for patients worldwide.
With over 150 leading companies, 300+ topline brands and knowledge-led conference sessions, the event is set to make a grand return to the South
Pharmaceutical sales was flat and stood at Rs. 309 crore as compared to Rs. 308 crore in Q4 FY22
The New State-of-Art OligoPilot 2000 solid-phase synthesizer adds cGMP manufacturing capacity to support and accelerate clinical and commercial oligonucleotide programs.
To enable company to be future-ready by tapping potential in CDMO space
Open, scalable, end-to-end solution to improve diagnostic quality and efficiency
Time to combine innovation, access and technology to deliver positive patient outcomes
Smart-performance, fully biodegradable biopolymer sourced from renewable raw materials
Nearly 5000 executives and more than 350 exhibitors turned out at the largest post-pandemic pharma packaging event
Subscribe To Our Newsletter & Stay Updated
